Latest Insider Transactions at Inari Medical, Inc. (NARI)
This section provides a real-time view of insider transactions for Inari Medical, Inc. (NARI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Inari Medical, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Inari Medical, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 10
2021
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+6.42%
|
$0
$0.46 P/Share
|
|
May 05
2021
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
30,000
-0.46%
|
$3,090,000
$103.62 P/Share
|
|
Apr 27
2021
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-5.84%
|
$565,000
$113.17 P/Share
|
|
Apr 27
2021
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+10.19%
|
$0
$0.05 P/Share
|
|
Apr 19
2021
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
9,000
-1.41%
|
$927,000
$103.26 P/Share
|
|
Apr 09
2021
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-2.34%
|
$560,000
$112.45 P/Share
|
|
Apr 09
2021
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+6.42%
|
$0
$0.46 P/Share
|
|
Apr 09
2021
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.05%
|
$784,000
$112.45 P/Share
|
|
Apr 05
2021
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
150,000
-2.37%
|
$16,050,000
$107.96 P/Share
|
|
Apr 01
2021
|
Thomas Tu Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
252
-0.64%
|
$27,468
$109.21 P/Share
|
|
Apr 01
2021
|
Andrew Hykes President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
360
-0.17%
|
$39,240
$109.21 P/Share
|
|
Apr 01
2021
|
Hill, Mitch C. Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
253
-0.37%
|
$27,577
$109.21 P/Share
|
|
Apr 01
2021
|
William Hoffman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
459
-0.04%
|
$50,031
$109.21 P/Share
|
|
Mar 26
2021
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.97%
|
$515,000
$103.13 P/Share
|
|
Mar 26
2021
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+10.13%
|
$0
$0.46 P/Share
|
|
Mar 19
2021
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
9,000
-0.82%
|
$981,000
$109.3 P/Share
|
|
Mar 17
2021
|
Andrew Hykes President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+8.23%
|
$0
$0.43 P/Share
|
|
Mar 16
2021
|
Donald B Milder Director |
SELL
Bona fide gift
|
Indirect |
210,000
-4.38%
|
-
|
|
Mar 16
2021
|
Presidio Management Group X LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
763,123
+37.07%
|
-
|
|
Mar 16
2021
|
Presidio Management Group X LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
3,389,513
-66.67%
|
-
|
|
Mar 16
2021
|
Jonathan D Root Director |
BUY
Other acquisition or disposition
|
Direct |
94,101
+18.03%
|
-
|
|
Mar 16
2021
|
Jonathan D Root Director |
SELL
Other acquisition or disposition
|
Indirect |
3,389,513
-66.67%
|
-
|
|
Mar 16
2021
|
Jonathan D Root Director |
BUY
Other acquisition or disposition
|
Indirect |
685,827
+50.0%
|
-
|
|
Mar 15
2021
|
William Hoffman Director |
SELL
Bona fide gift
|
Direct |
2,165
-0.23%
|
-
|
|
Mar 15
2021
|
Gilde Healthcare Iv U.A. Cooperatieve > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,200,000
-3.11%
|
$138,000,000
$115.03 P/Share
|
|
Mar 12
2021
|
Gilde Healthcare Iv U.A. Cooperatieve > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
250,000
-0.71%
|
$29,250,000
$117.43 P/Share
|
|
Mar 12
2021
|
Kirk G. Nielsen Director |
SELL
Open market or private sale
|
Direct |
206
-0.44%
|
$24,720
$120.0 P/Share
|
|
Mar 11
2021
|
Kirk G. Nielsen Director |
SELL
Other acquisition or disposition
|
Indirect |
721,574
-100.0%
|
-
|
|
Mar 11
2021
|
Kirk G. Nielsen Director |
BUY
Other acquisition or disposition
|
Direct |
7,955
+14.6%
|
-
|
|
Mar 11
2021
|
Kirk G. Nielsen Director |
BUY
Other acquisition or disposition
|
Indirect |
147,021
+50.0%
|
-
|
|
Mar 10
2021
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.02%
|
$812,000
$116.61 P/Share
|
|
Mar 09
2021
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.4%
|
$480,000
$96.94 P/Share
|
|
Mar 09
2021
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+6.39%
|
$0
$0.46 P/Share
|
|
Mar 05
2021
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
30,000
-0.33%
|
$2,760,000
$92.88 P/Share
|
|
Feb 26
2021
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-2.93%
|
$515,000
$103.16 P/Share
|
|
Feb 26
2021
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+10.13%
|
$0
$0.46 P/Share
|
|
Feb 19
2021
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
9,000
-0.86%
|
$1,053,000
$117.44 P/Share
|
|
Feb 11
2021
|
Hill, Mitch C. Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,690
+13.55%
|
-
|
|
Feb 11
2021
|
Thomas Tu Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,690
+21.61%
|
-
|
|
Feb 11
2021
|
William Hoffman Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,380
+1.85%
|
-
|
|
Feb 11
2021
|
Andrew Hykes President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
16,030
+7.03%
|
-
|
|
Feb 10
2021
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.03%
|
$798,000
$114.58 P/Share
|
|
Feb 09
2021
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.64%
|
$570,000
$114.58 P/Share
|
|
Feb 09
2021
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+7.41%
|
$0
$0.46 P/Share
|
|
Feb 05
2021
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
30,000
-0.44%
|
$3,330,000
$111.95 P/Share
|
|
Jan 27
2021
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.62%
|
$495,000
$99.68 P/Share
|
|
Jan 27
2021
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+13.13%
|
$0
$0.46 P/Share
|
|
Jan 20
2021
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
20,000
-0.58%
|
$2,020,000
$101.33 P/Share
|
|
Jan 20
2021
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
12,000
-15.4%
|
$1,200,000
$100.92 P/Share
|
|
Jan 20
2021
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+23.04%
|
$0
$0.46 P/Share
|